Clinical features, microbiology and surgical outcomes of infective endocarditis: a 13-year study from a UK tertiary cardiothoracic referral centre
Authors:
- D.J.B. MarksDMD.J.B. Marks
- C. HyamsCHC. Hyams
- C.Y. KooCKC.Y. Koo
- M. PavlouMPM. Pavlou
- J. RobbinsJRJ. Robbins
- C.S. KooCKC.S. Koo
- G. RodgerGRG. Rodger
- J.F. HuggettJHJ.F. Huggett
- J. YapJYJ. Yap
- M.B. MacraeMMM.B. Macrae
- R.H. SwantonRSR.H. Swanton
- A.I. ZumlaAZA.I. Zumla
Open Access
- 15 September 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 108 (3) , 219-229
Abstract
Background: Infective endocarditis (IE) causes substantial morbidity and mortality. Patient and pathogen profiles, as well as microbiological and operative strategies, continue to evolve. The impact of these changes requires evaluation to inform optimum management and identify individuals at high risk of early mortality. Aim: Identification of clinical and microbiological features, and surgical outcomes, among patients presenting to a UK tertiary cardiothoracic centre for surgical management of IE between 1998 and 2010. Design: Retrospective observational cohort study. Methods: Clinical, biochemical, microbiological and echocardiographic data were identified from clinical records. Principal outcomes were all-cause 28-day mortality and duration of post-operative admission. Results: Patients (n = 336) were predominantly male (75.0%); median age 52 years (IQR = 41–67). Most cases involved the aortic (56.0%) or mitral (53.9%) valves. Microbiological diagnoses, obtained in 288 (85.7%) patients, included streptococci (45.2%); staphylococci (34.5%); Haemophilus, Actinobacillus, Cardiobacterium, Eikenella, Kingella (HACEK) organisms (3.0%); and fungi (1.8%); 11.3% had polymicrobial infection. Valve replacement in 308 (91.7%) patients included mechanical prostheses (69.8%), xenografts (24.0%) and homografts (6.2%). Early mortality was 12.2%, but fell progressively during the study (P = 0.02), as did median duration of post-operative admission (33.5 to 10.5 days; P = 0.0003). Multivariable analysis showed previous cardiothoracic surgery (OR = 3.85, P = 0.03), neutrophil count (OR = 2.27, P = 0.05), albumin (OR = 0.94, P = 0.04) and urea (OR = 2.63, P < 0.001) predicted early mortality. Conclusions: This study demonstrates reduced post-operative early mortality and duration of hospital admission for IE patients over the past 13 years. Biomarkers (previous cardiothoracic surgery, neutrophil count, albumin and urea), predictive of early post-operative mortality, require prospective evaluation to refine algorithms, further improve outcomes and reduce healthcare costs associated with IE.Keywords
This publication has 34 references indexed in Scilit:
- A Nationwide Cohort Study of Mortality Risk and Long-Term Prognosis in Infective Endocarditis in SwedenPLOS ONE, 2013
- Management of infective endocarditis: challenges and perspectivesThe Lancet, 2012
- Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial ChemotherapyJournal of Antimicrobial Chemotherapy, 2011
- Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st CenturyArchives of internal medicine (1960), 2009
- 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart DiseaseCirculation, 2008
- A Systematic Review of Population-Based Studies of Infective EndocarditisChest, 2007
- Contemporary Clinical Profile and Outcome of Prosthetic Valve EndocarditisJAMA, 2007
- Infective endocarditisThe Lancet, 2004
- Active Native Valve Endocarditis: Determinants of Operative Death and Late MortalityThe Annals of Thoracic Surgery, 1997
- Hospital-Acquired Infectious Endocarditis Not Associated with Cardiac Surgery: An Emerging ProblemClinical Infectious Diseases, 1995